Market Place
Sourcing Support
Regulator Steps Up Oversight Of GLP-1 Drug Distribution Chain
28 Mar 2026 //
ECONOMICTIMES
Telangana DCA Issues Safety Advisory On Use Of Semaglutide
26 Mar 2026 //
PHARMABIZ
Novartis Sued Over Third-Party Data Sharing From Branded Sites
25 Mar 2026 //
FIERCE PHARMA
Centre Enhances GLP-1 Drug Oversight Due To Concerns Practices
25 Mar 2026 //
ECONOMICTIMES
CSL adds warning to Flucelvax label
25 Mar 2026 //
FIERCE PHARMA
GAO calls on FDA to finalize guidance on adcomm COI
24 Mar 2026 //
RAPS
DCGI Intensifies Crackdown on GLP-1 Drug Misuse, Misleading Ads
24 Mar 2026 //
ECONOMICTIMES
Government Enhances Oversight On Unauthorized GLP-1 Sales
24 Mar 2026 //
BUSINESS STD
Immunitybio Hit With FDA Warning Letter Over Anktiva Promotions
24 Mar 2026 //
FIERCE PHARMA
Lilly Plots European Discontinuations Of Certain Insulin Products
24 Mar 2026 //
FIERCE PHARMA
Indian Drugmakers Flood Market With Cheap Ozempic, Wegovy Copies
23 Mar 2026 //
ECONOMICTIMES
India’s drug regulator flags 90 unapproved FDCs
23 Mar 2026 //
ECONOMICTIMES
US FDA flags seizure risk with certain Parkinson`s drugs
21 Mar 2026 //
FDA
Investors Target Pharma QC as Drug Safety Surges
20 Mar 2026 //
PHARMIWEB
Intuitive Recalls Surgical Stapler Reloads After Patient Death
20 Mar 2026 //
FIERCE BIOTECH
CDSCO Urges Slas To Adopt Uniform Licensing Guidance
20 Mar 2026 //
PHARMABIZ
Industry Strengthens Shield Against Counterfeits At TAF 2026
20 Mar 2026 //
PHARMABIZ
ASCP Endorses Reforms After OIG Antipsychotic Reports
20 Mar 2026 //
PHARMIWEB
CDSCO Requests SLAs To Revoke Approval For Sodium Hyaluronate
20 Mar 2026 //
PHARMABIZ
FDA Warns Indian And German Firms For GMP, BIMO Violations
19 Mar 2026 //
RAPS
DentaBiome Issues 2026 Oral Postbiotic Consumer Warning Report
17 Mar 2026 //
GLOBENEWSWIRE
Health Ministry Amends D&C Rules To Mandate PACs Submission
16 Mar 2026 //
PHARMABIZ
KSRPO alerts state FDA about spurious drugs sold by fake doctor
16 Mar 2026 //
PHARMABIZ
DTAB Recommends Exemptions From Revised Schedule M Norms
16 Mar 2026 //
PHARMABIZ
TNHDA Urges Major Drug Regulatory Reforms After Coldrif Cough
16 Mar 2026 //
PHARMABIZ
APL Healthcare`s Unit-IV Classified As VAI By The USFDA
14 Mar 2026 //
INDPHARMAPOST
India`s Drug Quality Surveillance Surpasses 500K Samples Tested
13 Mar 2026 //
PHARMABIZ
CDSCO Advises Against Promoting Prescription Obesity Drugs
12 Mar 2026 //
EXPRESSPHARMA
Lilly Finds Impurity in Compounded Version of Weight-loss Drug
12 Mar 2026 //
REUTERS
Novo Nordisk receives FDA warning linked to US inspection in 2025
11 Mar 2026 //
REUTERS
FDA Moves to Address Manufacturing-Related Approval Rejections
10 Mar 2026 //
BIOSPACE
EDQM Approves Anuh Pharma Facility as Audit-Compliant
10 Mar 2026 //
EXPRESSPHARMA
FDA Official Reveals Key GMP Violations In Inspection Reports
09 Mar 2026 //
RAPS
Lupin Gets 2 Observations From USFDA For Ankleshwar Site
09 Mar 2026 //
INDPHARMAPOST
Incyte Lung Cancer Expansion Hit by Issues at Novo Catalent Site
09 Mar 2026 //
BIOSPACE
Cipla USA Recalls Nilotinib Capsules Over Manufacturing Issue
09 Mar 2026 //
ECONOMICTIMES
FDA Issues Draft Guidance on Inspection Response Best Practices
06 Mar 2026 //
RAPS
FDA Cites Novo Nordisk Again For Misleading GLP-1 AD
05 Mar 2026 //
RAPS
BDCDA alerts fraternity about theft of Lantus SoloStar of Sanofi
05 Mar 2026 //
PHARMABIZ
FDA Issues 30 Warning Letters For Compounded GLP-1s Clampdown
04 Mar 2026 //
BIOSPACE
Abbott Faces Trial Over Infant Formula Disease Claims
04 Mar 2026 //
REUTERS
Novo Earns FDA Untitled Letter For Apple-Inspired Ozempic Ad
04 Mar 2026 //
FIERCE PHARMA
FDA Rejection Letters Flag Data Concerns For AZ, GSK Biologics
03 Mar 2026 //
FIERCE PHARMA
Feinstein Institutes Research Uncovers Early Brain Signs
02 Mar 2026 //
BUSINESSWIRE
Icosapent Ethyl Reduces Hospitalization And Death Risk
02 Mar 2026 //
GLOBENEWSWIRE
Viatris To Cut 10% Of Workforce In 3-Year Overhaul
26 Feb 2026 //
FIERCE PHARMA
Drug Industry Groups And Combo Products Seek Clarity
25 Feb 2026 //
RAPS
FDA Intensifies Enforcement Against Non-Compliant Cough Syrup
24 Feb 2026 //
ECONOMICTIMES
Telangana`s DCA Conducts Consecutive Raids Against Illegal Drug
24 Feb 2026 //
PHARMABIZ
Supreme Court Seeks Centre`s Response On Micro Labs` Plea
24 Feb 2026 //
ECONOMICTIMES
FDA Freezes Enrollment In Macrogenics Cancer Trial After Death
24 Feb 2026 //
FIERCE BIOTECH
India Inspects 90% of Cough Syrup Makers
24 Feb 2026 //
ECONOMICTIMES
Health Ministry Notifies Several Amendments To D&C Rules, 1945
23 Feb 2026 //
PHARMABIZ
CDSCO Eases NOC Norms For Clinical Research Acceleration
23 Feb 2026 //
BUSINESS STD
Industry clamors for clearer guidance on transition to ICH M4Q
23 Feb 2026 //
RAPS
Pondicherry Health Department Issues Safety Update
23 Feb 2026 //
PHARMABIZ
Cassidy Identifies Fda Regulatory `Black Box` Improvements
19 Feb 2026 //
BIOSPACE
FDA Untitled Letter Lambastes Claims In Ad For J&J`s Tremfya
19 Feb 2026 //
FIERCE PHARMA
Pharma Firms Asked For Side-Effects Of Common Medicines
19 Feb 2026 //
ECONOMICTIMES
NHS Confederation Reacts To NHS England Letter On Bone Cement
18 Feb 2026 //
PHARMIWEB
